At Johnson & Johnson Innovation, we are searching for top notch science, and we know that a great idea can come from anywhere. We also know that no two environments are made the same, and at the Asia Pacific Innovation Center we are working to find great science and accelerate entrepreneurship across a vast and diverse region.
Translating the best science into first-in-class, best-in-class health care solutions means applying the right nutrients to the ecosystem: deep science, access to capital and passionate entrepreneurs.
Once we began to dive into this region, we find a diverse ecosystem across countries that require different nutrients in order to accelerate their development. For example, risk taking entrepreneurs in Japan, access to venture capital in Australia and advanced science in China.
The region also has a significant scientific diaspora – students, researchers and scientific entrepreneurs – that once left their country to explore opportunities around the world, but who are now interested in returning to contribute to their country and the region, especially in China.
Into this environment Johnson & Johnson launched the Asia Pacific Innovation Center in October 2014, and as we celebrate our one-year anniversary, we are finding traction with new and insightful ways to engage the best science in the region, and accelerating entrepreneurship in the local ecosystems where we operate.
One example of our practical and flexible approach is a collaboration that was recently signed between ViroGin Biotech and Johnson & Johnson Innovation.
ViroGin is a promising startup in the field of oncolytic virotherapy with decades of experience in the field. Work on its technology started in the 1990’s with the first clinical trials conducted in China. Extensive research and development continued in Canada for many years and currently ViroGin has established R&D facilities and operations in Vancouver, Canada as well as Shenzhen, China. In October of this year, ViroGin entered into a collaboration with Johnson & Johnson Innovation and Janssen Biotech, Inc. (“Janssen”) to continue to develop their technology.
Through these types of collaborations, we strive to continue our efforts to de-risk and push exciting advancements in deep science forward into best-in-class outcomes that will have a positive impact on patients and help scientific entrepreneurs reach their dreams and save lives.
As we celebrate our one-year anniversary in the region, Johnson & Johnson Innovation is continuing to find new ways to build and support a vibrant innovation ecosystem. We see a region that has all of the right ingredients for success, and innovation that promises to be truly transformational in meeting the world’s most pressing healthcare needs.
If you have what we are looking for, or know someone who does, we want to hear from you.
Head, Johnson & Johnson Innovation, Asia Pacific Innovation Center.
Email: email@example.com, mobile: +86 139 0194 8775